Search the Newsreel

Why Valor Gold Corp. stock is skyrocketing today

FMR LLC discloses 10.8% Avalo Therapeutics (AVTX) holding in Schedule 13G/A

FMR LLC has filed an amended Schedule 13G/A, disclosing a beneficial ownership of 5,737,966 shares of Avalo Therapeutics, Inc. (AVTX), which represents 10.8% of the company's common stock. The filing indicates FMR LLC holds sole dispositive power over all these shares and sole voting …

State Street Corporation (NYSE: AVTX custodian) discloses 5.5% Avalo stake

State Street Corporation has disclosed a 5.5% beneficial ownership stake in Avalo Therapeutics, Inc. (AVTX) through a Schedule 13G filing. The investment firm reported owning 2,889,287 shares, with shared voting power over 2,837,724 shares and shared dispositive power over all 2,889,287 shares. Subsidiaries involved …

Avalo Therapeutics Releases Q2 2026 Financial Results

Avalo Therapeutics reported narrower losses for Q2 2026, with a net loss of $36.4M and a loss of $0.83 per share, significantly improving from the prior year. The clinical-stage biotechnology company is developing IL-1ß-based treatments and maintains a positive outlook from Wall Street analysts. …

Avalo Therapeutics, Inc. Stock 12‑Month Price Target Raised to $45.33, Implies 141% Upside

Avalo Therapeutics, Inc.'s stock price target has been increased to $45.33 from $44.69 by 12 analysts, implying a potential upside of 141% from its August 5th closing price. The consensus rating from 14 covering analysts remains a "Buy," with no "Holds" or "Sells."

Price-Driven Insight from (AVTX) for Rule-Based Strategy

This article provides a price-driven analysis for Avalo Therapeutics Inc. (NASDAQ: AVTX), highlighting weak near-term sentiment but potential long-term strength. It outlines three AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels, along with a multi-timeframe signal analysis. The …

Avalonbay Communities Inc. stock underperforms Thursday when compared to competitors

Shares of Avalonbay Communities Inc. (AVB) fell 1.61% on Thursday to $186.55, underperforming the broader market. This drop ended a three-day winning streak for the company's stock, as both the S&P 500 Index and Dow Jones Industrial Average also declined during the trading session.

AvalonBay Communities, Inc. (AVB) Stock Forecasts

A Morningstar analyst report from July 28, 2026, discusses AvalonBay Communities, Inc. (AVB), highlighting that its expense growth remains above revenue growth, though not as high as initially feared. The report provides an overview of AvalonBay's portfolio of 296 apartment communities and 24 additional …

Avalo Therapeutics, Inc. 2026: Revenue ($36.94M), Net income ($36.36M), EPS ($0.83) — 10-Q Summary

Avalo Therapeutics, Inc. reported a comprehensive loss of ($36.94M) and a net loss of ($36.36M) for the quarter ended 2026, with diluted loss per share at ($0.83). The company achieved positive Phase 2 results for abdakibart in hidradenitis suppurativa and completed a $405M equity …

VRL Logistics, Avalon Technologies, Blue Dart Shares In Focus As Motilal Oswal Stays Bullish After Q1— Check Target Prices

Avalo Therapeutics (NASDAQ:AVTX) Issues Quarterly Earnings Results, Misses Expectations By $0.27 EPS

Stocks in play: Avalon Advanced Materials Inc.

Mid-America Apartment Communities Vs. W. P. Carey: Why One REIT Dividend Claimed 86% Of Core AFFO

This article compares the dividend payout ratios of Mid-America Apartment Communities (MAA) and W. P. Carey (WPC) based on their second-quarter 2026 earnings. MAA's dividend consumed 86% of its Core AFFO, while W. P. Carey's used 70% of its reported AFFO. The article delves …

Avalon Technologies Q1 Results: Earnings call audio released

Avalon Technologies Q1 Results: Net Profit Jumps 145% YoY, EBITDA Margin Expands

Avalon Technologies net profit jumps 145% in Q1FY27 on margin expansion

ETFs Investing in AvalonBay Communities, Inc. Stocks

This article lists various ETFs that hold stocks of AvalonBay Communities, Inc. (AVB), a real estate investment trust. The funds are sorted by market value and include details such as weight in the fund, issuer, management style, expense ratio, assets under management (AUM), and …

Avalonbay Communities Inc. stock outperforms competitors on strong trading day

Avalonbay Communities Inc. (AVB) stock rose 1.71% to $188.78 on Monday, outperforming its competitors and the broader market. This increase broke a two-day losing streak for the company. The S&P 500 Index also saw a gain of 1.48%, and the Dow Jones Industrial Average …

Avalo Therapeutics Inc expected to post a loss of 58 cents a share - Earnings Preview

Avalo Therapeutics Inc is projected to report a loss of 58 cents per share in its upcoming earnings release. This forecast is based on an earnings preview from Refinitiv. The full article content is behind a paywall, requiring a TradingView subscription for unlimited access.

AvalonBay Communities, Inc. $AVB Shares Bought by Bank of America Corp DE

Bank of America Corp DE increased its stake in AvalonBay Communities (NYSE:AVB) by 10.8% in the first quarter, now owning 2.20 million shares valued at approximately $360.1 million. Other institutional investors also adjusted their positions, collectively owning 92.61% of the REIT. Despite missing earnings …

AVB4408804 Bond Profile — Key Metrics

This article provides a detailed profile of the AVB4408804 bond issued by AvalonBay Communities, Inc. Key metrics such as coupon rate (2.9%), issue date (Oct 5, 2016), maturity date (Oct 15, 2026), and outstanding amount ($300 million USD) are highlighted. AvalonBay Communities, Inc. is …

AvalonBay Communities (AVB) And Equity Residential Unveil Vivmark Residential In Merger Of Equals

AvalonBay Communities (AVB) and Equity Residential have announced a "merger of equals" to form a new company named Vivmark Residential, creating one of the largest multifamily residential real estate companies. This merger will combine over 180,000 apartments and 10,000 units under construction, positioning Vivmark …

AvalonBay Communities (AVB) Could Be 8% Below Fair Value As Merger Plans Progress

AvalonBay Communities (AVB) is currently considered undervalued by about 7.9%, with a fair value estimated at $201.44 against a last close of $185.61. This valuation is influenced by strong apartment demand, demographic trends, and progress on its merger with Vivmark Residential. Investors are advised …

Amundi Buys 123,330 Shares of AvalonBay Communities, Inc. $AVB

Amundi increased its holdings in AvalonBay Communities, Inc. (NYSE:AVB) by 24.2% during the first quarter, acquiring an additional 123,330 shares to own a total of 633,842 shares valued at $103.54 million. Other institutional investors also adjusted their stakes, with hedge funds and institutional investors …

DV Trading LLC Invests $5.38 Million in Avalo Therapeutics, Inc. $AVTX

Avalo Therapeutics Inc Revenue Breakdown – DUS:C6K0

Avalo Therapeutics Inc (DUS:C6K0) generated 50.23K EUR last year, a significant decrease from 426.00K EUR the previous year. The pharmaceutical segment was its top-performing segment, contributing all of the company's revenue, and the United States was the primary source of this revenue.

AvalonBay Communities, Inc. $AVB Shares Purchased by Groupe la Francaise

Groupe la Francaise increased its stake in AvalonBay Communities (NYSE:AVB) by 22.2% in the first quarter, now holding 32,072 shares valued at $5.24 million. Institutional investors and hedge funds collectively own 92.61% of the company's stock, which has a consensus "Hold" rating and an …

AvalonBay Communities (AVB) Issues Supplemental Disclosures for Equity Residential Merger Amid Shareholder Litigation

AvalonBay Communities (AVB) has voluntarily issued supplemental disclosures for its proposed all-stock merger with Equity Residential, forming Vivmark Residential. This action addresses shareholder complaints alleging deficiencies in the original proxy statement, despite the company's belief that the allegations lack merit. The disclosures include detailed …

AvalonBay (NYSE: AVB) adds merger litigation and valuation detail

Equity Residential and AvalonBay Communities have provided supplemental information regarding their proposed all-stock merger-of-equals, Vivmark Residential, addressing demand letters and shareholder lawsuits challenging prior disclosures. The update includes details on negotiations with "Company A" and expanded valuation analyses by Morgan Stanley and Goldman Sachs, …

[425] AVALONBAY COMMUNITIES INC Business Combination Communication

AvalonBay Communities Inc. (AVB) filed a Form 425 communication regarding its proposed all-stock merger-of-equals with Equity Residential. The filing addresses litigation from purported stockholders concerning alleged disclosure deficiencies in the definitive joint proxy statement/prospectus. AvalonBay and Equity Residential are voluntarily providing supplemental disclosures to …

AvalonBay to Combine with Equity Residential in All-Stock Merger; Registrations Effective, Litigation Disclosed

AvalonBay Communities (AVB) announced an all-stock merger-of-equals with Equity Residential, forming Vivmark Residential. Regulatory filings for the merger are effective, and while several shareholder lawsuits alleging disclosure deficiencies have been filed, both companies deny their merit and have provided supplemental disclosures to avoid delays.

[8-K] AVALONBAY COMMUNITIES INC Reports Material Event

AvalonBay Communities (AVB) filed an 8-K to supplement the definitive joint proxy statement/prospectus for its proposed all-stock merger with Equity Residential. The filing addresses shareholder litigation alleging disclosure deficiencies, which the companies deny, and provides updated financial analyses, including Goldman Sachs's pro forma present-value …

Avalo Therapeutics Inc (AVTX) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Avalo Therapeutics Inc (AVTX), focusing on its price momentum, support and resistance levels, and various technical indicators and moving averages. As of the analysis, AVTX has a price momentum score of 3.95 and is trading between a …

Avalonbay Communities Inc. stock underperforms Friday when compared to competitors

Avalonbay Communities Inc. (AVB) stock fell by 1.16% on Friday, closing at $185.61. This underperformance occurred despite a positive trading session for the broader market, with both the S&P 500 Index and the Dow Jones Industrial Average posting gains. This marks the second consecutive …

AvalonBay (AVB) and Equity Residential to form Vivmark Residential with $71B enterprise value

AvalonBay Communities and Equity Residential are set to merge and operate under the new name Vivmark Residential, forming a multifamily real estate platform with an estimated equity market capitalization of $53 billion and an enterprise value of $71 billion. The combined entity will manage …

AvalonBay Communities 2Q 2026: Revenue $777.8M, EPS $1.11— 10-Q Summary

AvalonBay Communities (AVB) reported Q2 2026 revenue of $777.8 million, a 2.3% increase year-over-year, while net income and diluted EPS saw significant declines due to higher operating and transaction costs related to a merger. Despite these costs, Same Store Residential NOI rose 1.0%, and …